| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Venlafaxine Hydrochloride | FAERS: 7 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 2 | Ondansetron | FAERS: 6 | US FAERS | |
| 3 | Fluoxetine | FAERS: 5 | US FAERS | |
| 4 | Valproic Acid | FAERS: 5 | US FAERS | |
| 5 | Norgestrel | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance OFFSIDES US FAERS | |
| 6 | Clozapine | FAERS: 3 | US FAERS | |
| 7 | Imatinib Mesylate | FAERS: 3 | US FAERS | |
| 8 | Ranitidine | FAERS: 3 | US FAERS | |
| 9 | Topiramate | FAERS: 3 | US FAERS | |
| 10 | Carbamazepine | FAERS: 2 | US FAERS | |
| 11 | Fluoxetine | FAERS: 2 | US FAERS | |
| 12 | Thyroxine | FAERS: 2 | US FAERS | |
| 13 | Thyroxine | FAERS: 2 | US FAERS | |
| 14 | 17 alpha-Hydroxyprogesterone Caproate | FAERS: 1 | US FAERS | |
| 15 | Amoxicillin-Potassium Clavulanate Combination | FAERS: 1 | US FAERS | |
| 16 | Aripiprazole | FAERS: 1 | US FAERS | |
| 17 | Buprenorphine | FAERS: 1 | US FAERS | |
| 18 | Citalopram | FAERS: 1 | US FAERS | |
| 19 | Citalopram | FAERS: 1 | US FAERS | |
| 20 | Clonazepam | FAERS: 1 | US FAERS | |
| 21 | Diazepam | FAERS: 1 | US FAERS | |
| 22 | Dopamine | FAERS: 1 | US FAERS | |
| 23 | Isotretinoin | FAERS: 1 | US FAERS | |
| 24 | Lamotrigine | FAERS: 1 | US FAERS | |
| 25 | Lurasidone Hydrochloride | FAERS: 1 | US FAERS | |
| 26 | Methadone | FAERS: 1 | US FAERS | |
| 27 | Nevirapine | FAERS: 1 | US FAERS | |
| 28 | Ramipril | FAERS: 1 | US FAERS | |
| 29 | Tussicaps | FAERS: 1 | US FAERS | |
| 30 | Valproic Acid | FAERS: 1 | US FAERS | |
| 31 | Valproic Acid | FAERS: 1 | US FAERS | |
| 32 | olsalazine | FAERS: 1 | US FAERS | |
| 33 | Etomidate | OFFSIDES | ||
| 34 | Imipramine | Canada Vigilance: 1 | Canada Vigilance |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.